DK151801C - Analogifremgangsmaade til fremstilling af 1-(benzimidazolylpropyl)-4-substituerede piperidinderivater - Google Patents
Analogifremgangsmaade til fremstilling af 1-(benzimidazolylpropyl)-4-substituerede piperidinderivaterInfo
- Publication number
- DK151801C DK151801C DK452076A DK452076A DK151801C DK 151801 C DK151801 C DK 151801C DK 452076 A DK452076 A DK 452076A DK 452076 A DK452076 A DK 452076A DK 151801 C DK151801 C DK 151801C
- Authority
- DK
- Denmark
- Prior art keywords
- substituted
- preparing
- analogy procedure
- piperide
- ingredients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62072775A | 1975-10-08 | 1975-10-08 | |
| US62072775 | 1975-10-08 | ||
| US05/713,309 US4035369A (en) | 1975-10-08 | 1976-08-10 | 1-Benzazolylalkyl-4-substituted-piperidines |
| US71330976 | 1976-08-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK452076A DK452076A (da) | 1977-04-09 |
| DK151801B DK151801B (da) | 1988-01-04 |
| DK151801C true DK151801C (da) | 1988-06-06 |
Family
ID=27088773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK452076A DK151801C (da) | 1975-10-08 | 1976-10-07 | Analogifremgangsmaade til fremstilling af 1-(benzimidazolylpropyl)-4-substituerede piperidinderivater |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4035369A (nl) |
| JP (1) | JPS5246082A (nl) |
| AT (1) | AT365185B (nl) |
| AU (1) | AU511834B2 (nl) |
| BG (1) | BG27542A3 (nl) |
| CA (1) | CA1085853A (nl) |
| CH (1) | CH630915A5 (nl) |
| CS (1) | CS225101B2 (nl) |
| DE (1) | DE2645125A1 (nl) |
| DK (1) | DK151801C (nl) |
| EG (1) | EG12969A (nl) |
| ES (1) | ES452200A1 (nl) |
| FI (1) | FI63228C (nl) |
| FR (1) | FR2346009A1 (nl) |
| GB (1) | GB1532546A (nl) |
| GR (1) | GR61672B (nl) |
| HU (1) | HU174927B (nl) |
| IE (1) | IE43951B1 (nl) |
| IL (1) | IL50631A (nl) |
| IT (1) | IT1069293B (nl) |
| LU (1) | LU75954A1 (nl) |
| NL (1) | NL7611085A (nl) |
| NO (1) | NO144926C (nl) |
| NZ (1) | NZ182134A (nl) |
| PH (1) | PH15417A (nl) |
| PL (1) | PL106815B1 (nl) |
| PT (1) | PT65688B (nl) |
| RO (1) | RO69904A (nl) |
| SE (1) | SE417610B (nl) |
| SU (1) | SU663306A3 (nl) |
| YU (1) | YU39976B (nl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| EP0034116A3 (en) * | 1980-02-11 | 1981-09-02 | Berlex Laboratories, Inc. | N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
| US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
| DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
| KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| DE69531476T2 (de) | 1994-09-12 | 2004-06-09 | Lilly Industries Ltd., Basingstoke | Serotonergische Modulatoren |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
| AU2007298770B2 (en) * | 2006-09-19 | 2013-01-31 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal form |
| CN101759693B (zh) * | 2008-12-23 | 2011-09-14 | 江苏恩华药业股份有限公司 | 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用 |
| CA3211341A1 (en) * | 2021-03-19 | 2022-09-22 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (nl) * | 1962-06-13 | |||
| US3225052A (en) * | 1964-05-06 | 1965-12-21 | Janssen Pharmaceutica Nv | Benzimidazolinyl piperidine derivatives |
| FR1573739A (nl) | 1968-07-26 | 1969-07-04 | ||
| US3635982A (en) * | 1969-04-08 | 1972-01-18 | American Home Prod | Amino-substituted-quinoxalinyloxazolidines and -oxazines |
-
1976
- 1976-08-10 US US05/713,309 patent/US4035369A/en not_active Expired - Lifetime
- 1976-09-22 NZ NZ182134A patent/NZ182134A/xx unknown
- 1976-09-23 AU AU18078/76A patent/AU511834B2/en not_active Expired
- 1976-09-28 PH PH18950A patent/PH15417A/en unknown
- 1976-10-01 CA CA262,478A patent/CA1085853A/en not_active Expired
- 1976-10-05 EG EG605/76A patent/EG12969A/xx active
- 1976-10-05 GR GR51849A patent/GR61672B/el unknown
- 1976-10-05 FR FR7629928A patent/FR2346009A1/fr active Granted
- 1976-10-06 IT IT51612/76A patent/IT1069293B/it active
- 1976-10-06 DE DE19762645125 patent/DE2645125A1/de active Granted
- 1976-10-06 CH CH1265376A patent/CH630915A5/de not_active IP Right Cessation
- 1976-10-06 GB GB41465/76A patent/GB1532546A/en not_active Expired
- 1976-10-07 JP JP51119933A patent/JPS5246082A/ja active Granted
- 1976-10-07 NO NO763424A patent/NO144926C/no unknown
- 1976-10-07 LU LU75954A patent/LU75954A1/xx unknown
- 1976-10-07 IL IL50631A patent/IL50631A/xx unknown
- 1976-10-07 IE IE2212/76A patent/IE43951B1/en unknown
- 1976-10-07 PL PL1976192890A patent/PL106815B1/pl not_active IP Right Cessation
- 1976-10-07 PT PT65688A patent/PT65688B/pt unknown
- 1976-10-07 DK DK452076A patent/DK151801C/da not_active IP Right Cessation
- 1976-10-07 SE SE7611137A patent/SE417610B/xx not_active IP Right Cessation
- 1976-10-07 FI FI762865A patent/FI63228C/fi not_active IP Right Cessation
- 1976-10-07 ES ES452200A patent/ES452200A1/es not_active Expired
- 1976-10-07 AT AT0745276A patent/AT365185B/de active
- 1976-10-07 NL NL7611085A patent/NL7611085A/nl not_active Application Discontinuation
- 1976-10-08 RO RO197687960Q patent/RO69904A/ro unknown
- 1976-10-08 HU HU76JA771A patent/HU174927B/hu not_active IP Right Cessation
- 1976-10-08 YU YU2480/76A patent/YU39976B/xx unknown
- 1976-10-08 SU SU762407707A patent/SU663306A3/ru active
- 1976-10-08 BG BG7634394A patent/BG27542A3/xx unknown
- 1976-10-08 CS CS766511A patent/CS225101B2/cs unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK494876A (da) | Fremgangsmade til fremstilling af piperidinderivater | |
| DK145228C (da) | Analogifremgangsmaade til fremstilling af 3-amino-4-deoxo-4-iminorifamycinderivater | |
| DK154764C (da) | Analogifremgangsmaade til fremstilling af 1-sulfonylbenzimidazol-derivater | |
| DK562376A (da) | Fremgangsmade til fremstilling af ergolinderivater | |
| DK147068C (da) | Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater | |
| DK462376A (da) | Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater | |
| DK151801C (da) | Analogifremgangsmaade til fremstilling af 1-(benzimidazolylpropyl)-4-substituerede piperidinderivater | |
| DK243176A (da) | Fremgangsmade til fremstilling af polycliske forbindelser | |
| DK517776A (da) | Fremgangsmade til femstilling af heterocycliske forbindelser | |
| DK143452C (da) | Fremgangsmaade til fremstilling af en alkoholisk bryg | |
| DK127876A (da) | Fremgangsmade til fremstilling af nitrofurylpyrazolderivater | |
| DK145698C (da) | Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater | |
| DK164476A (da) | Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser | |
| DK324776A (da) | Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler | |
| DK305876A (da) | Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid | |
| DK97376A (da) | Fremgangsmade til fremstilling af histidinderivater | |
| DK276276A (da) | Fremgangsmade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater | |
| DK155598C (da) | Fremgangsmaade til fremstilling af ethylchlorthioformiat | |
| DK143281C (da) | Fremgangsmaade til fremstilling af phosphitchlorider | |
| DK143137C (da) | Fremgangsmaade til fremstilling af phosphitchlorider | |
| DK267976A (da) | Fremgangsmade til fremstilling af piperidiner | |
| DK511376A (da) | Fremgangsmade til fremstilling af imidazolforbindelser | |
| DK137759B (da) | Fremgangsmaade til fremstilling af 1-(tetrahydro2-furanyl)-5-fluoruracil | |
| DK154888C (da) | Analogifremgangsmaade til fremstilling af 6-substituerede-6-methoxypenicillansyrederivater | |
| DK66176A (da) | Fremgangsmade til fremstilling af substituerede imidazoler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |